Use of Eprex in Canada.
Légaré
Carole
C
Turner
Christopher
C
Klein
Anges V
AV
D001315:Australia; D002170:Canada; D000075202:Contraindications; D004335:Drug and Narcotic Control; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects*; D005060:Europe; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*
D011994:Recombinant Proteins; D004921:Erythropoietin